HDT Bio Launches Canadian clinical programme for brain cancer treatment

Accord BioPharma's second pegfilgrastim biosimilar to NEULASTA approved by US FDA

BiBBInstruments signs first European distribution deal for EndoDrill GI with Palex Spain

Northwest Biotherapeutics presents updated DCVax-L Phase III trial survival data for glioblastoma

HanchorBio plans combination research with late-stage cancer drug resistance specialist InxMed

GE HealthCare and Mayo Clinic launch prostate cancer theranostics research study

Physiomics secures new contracts worth over GBP200,000

Wiley announces launch of Advanced Immunology open access journal

EDX Medical to provide molecular profiling services to Astron Health

IceCure reports growing adoption of ProSense cryoablation in Brazil

PharmaEssentia secures Health Canada approval for BESREMi in polycythaemia vera

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Signatera study links MRD status to survival benefit from chemotherapy in colorectal liver metastases

Northwest Biotherapeutics presents on propensity score matching at BNOS 2026

Taiwan biomedical startups hold over 100 business meetings at BIO 2026